These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32418480)

  • 1. Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review.
    Abd El Aziz MA; Sacco R; Facciorusso A
    Antivir Chem Chemother; 2020; 28():2040206620921331. PubMed ID: 32418480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Timing and selection of antiviral therapy with nucleos(t)ide analogues for prevention of hepatitis B virus-related HCC].
    Han C; Lai PP; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):827-830. PubMed ID: 31941235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    Wang X; Liu X; Dang Z; Yu L; Jiang Y; Wang X; Yan Z
    Gut Liver; 2020 Mar; 14(2):232-247. PubMed ID: 31158948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis.
    Wang ML; Tang H
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):579-586. PubMed ID: 27919846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.
    Tseng CM; Chen TB; Hsu YC; Chang CY; Lin JT; Mo LR
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):421-429. PubMed ID: 27435683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis B.
    Orita N; Kawaguchi K; Honda M; Shimode T; Hayakawa N; Terashima T; Komura T; Nishikawa M; Horii R; Nio K; Shimakami T; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S; Kagaya T; Yamashita T
    Biochem Biophys Res Commun; 2023 Sep; 674():133-139. PubMed ID: 37419034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?
    Wang CC; Kao JH
    Expert Opin Pharmacother; 2016; 17(7):911-9. PubMed ID: 26831361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk.
    Ren P; Cao Z; Mo R; Liu Y; Chen L; Li Z; Zhou T; Lu J; Liu Y; Guo Q; Chen R; Zhou H; Xiang X; Cai W; Wang H; Bao S; Xu Y; Gui H; Xie Q
    Expert Opin Biol Ther; 2018 Oct; 18(10):1085-1094. PubMed ID: 30182763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
    Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.
    Chien RN; Liaw YF
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1081-92. PubMed ID: 19187868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
    Zhang MY; Zhu GQ; Shi KQ; Zheng JN; Cheng Z; Zou ZL; Huang HH; Chen FY; Zheng MH
    Oncotarget; 2016 May; 7(21):30642-58. PubMed ID: 27121321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma].
    Sun J; Zhang S; Wang YX; Zhu L; Xing HC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):721-724. PubMed ID: 31594101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients.
    Wang HM; Hung CH; Lee CM; Lu SN; Wang JH; Yen YH; Kee KM; Chang KC; Tseng PL; Hu TH; Chen CH
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1307-14. PubMed ID: 26758501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
    Okada M; Enomoto M; Kawada N; Nguyen MH
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Jian ZW; Wu XW; Chen ZX; Wang JC; Peng JY; Lao XM
    Dig Dis Sci; 2019 Aug; 64(8):2187-2198. PubMed ID: 30815819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives.
    Sun D; Zhu L; Yao D; Chen L; Fu L; Ouyang L
    Eur J Med Chem; 2018 Mar; 147():205-217. PubMed ID: 29438889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
    Coffin CS; Rezaeeaval M; Pang JX; Alcantara L; Klein P; Burak KW; Myers RP
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1262-9. PubMed ID: 25312649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis.
    Yu S; Jianqin H; Wei W; Jianrong H; Yida Y; Jifang S; Liang Y; Zhi C; Hongyu J
    Ann Hepatol; 2013; 12(3):364-72. PubMed ID: 23619252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.